Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Roche, Hologic, Cornell, USC, Others Win US Patents


Cornell Research Foundation has been awarded US Patent No. 8,642,269, "Detection of nucleic acid sequence differences using coupled polymerase chain reactions."

Francis Barany, Matthew Lubin, George Barany, Robert Hammer, and Phillip Belgrader are named as inventors.

Roche Diagnostics has been awarded US Patent No. 8,642,266, "Single cell mRNA quantification with real-time RT-PCR."

Martin Bergtsson, Michael Kubista, Anders Stahlberg, and Linda Stroembom are named as inventors.

Roche Molecular Systems has been awarded US Patent No. 8,642,293, "Disposable device for analyzing a liquid sample containing a nucleic acid with a nucleic acid amplification apparatus."

Emad Sarofim, Olivier Elsenhans, Martin Kopp, and Hans-Peter Wahl are named as inventors.

Zoragen Biotechnologies has been awarded US Patent No. 8,642,264, "Method of quantifying target and reference nucleic acid."

Nora Szasz is named as the inventor.

University of Southern California has been awarded US Patent No. 8,642,263, "Highthroughput methods comprising analysis of repetitive element DNA methylation."

Peter Laird, Daniel Weisenberger, Mihaela Campan, and Tifany Long are named as inventors.

Erasmus University Medical Center has been awarded US Patent No. 8,642,295, "Circular chromosome conformation capture (4C)."

Wouter De Laat and Frank Grosveld are named as inventors.

Gen-Probe (Hologic) has been awarded US Patent No. 8,642,268, "Methods and compositions for nucleic acid amplification."

Steven Brentano, Dmitry Lyakhov, James Carlson, Norman Nelson, Lyle Arnold Jr., and Michael Becker are named as inventors.

The US Army has been awarded US Patent No. 8,642,746, "Unique calibrator polynucleotides and methods of using in quantitative nucleic acid assays."

Christopher Phillips, Albert Ruff, and James Dillman III are named as inventors.

Washington University has been awarded US Patent No. 8,642,279, "Method for predicting risk of metastasis."

William Harbour is named as the inventor.

The Children's Hospital of Philadelphia has been awarded US Patent No. 8,642,265, "Compositions and methods for the detection of topoisomerase II complexes with DNA."

Carolyn Felix and Donald Baldwin are named as inventors.

Trovagene has been awarded US Patent No. 8,642,261, "Genetic marker for detection of human papillomavirus."

Hovsep Melkonyan, Samuil Umansky, and Zhenghan Xin are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.